Literature DB >> 17074508

Investigation by bioassay of the efficacy of sodium hydroxide treatment on the inactivation of mouse-adapted scrapie.

A Unal1, J Thyer, E Uren, D Middleton, M Braun, D Maher.   

Abstract

Sodium hydroxide (NaOH) has been shown to reduce the infectivity of transmissible spongiform encephalopathy (TSE) agents. This study investigated the efficacy of sodium hydroxide at 0.1M, 0.25M and 0.5M concentrations for the inactivation of mouse-adapted scrapie strain ME7. Times and temperatures modelled conditions used in an industrial plasma fractionation plant for sanitisation of ultrafilters, and the sodium hydroxide component of Clean In Place sanitisation. The concentration of scrapie ME7 brain homogenate in NaOH test solutions was 1% (w/v). At the end of incubation periods, the samples were adjusted to neutral pH prior to intracerebral inoculation into mice for bioassay. The conditions of 0.1M NaOH at 60 degrees C for 2min and 0.25M NaOH at 30 degrees C for 60min were found to inactivate 3.96 and 3.93logs of scrapie, respectively. Use of 0.5M NaOH at 30 degrees C for 60 or 75min was found to inactivate >or=4.23 and 4.15logs of scrapie. This indicates that the use of these conditions in an industrial process would substantially reduce prion infectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074508     DOI: 10.1016/j.biologicals.2006.08.003

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  2 in total

1.  Evaluation of a combinatorial approach to prion inactivation using an oxidizing agent, SDS, and proteinase K.

Authors:  Jodi D Smith; Eric M Nicholson; Justin J Greenlee
Journal:  BMC Vet Res       Date:  2013-07-25       Impact factor: 2.741

2.  Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity.

Authors:  Jodi D Smith; Eric M Nicholson; Gregory H Foster; Justin J Greenlee
Journal:  BMC Vet Res       Date:  2013-01-11       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.